Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1995 | 12-1994 | 12-1993 | 12-1992 | 12-1991 | |
| Sales | 1,106,681 | 448,948 | 380,061 | 315,165 | 230,035 |
| Cost of Goods | 315,981 | 162,201 | 140,233 | 116,532 | 81,836 |
| Gross Profit | 790,700 | 286,747 | 239,828 | 198,633 | 148,199 |
| Operating Expenses | 448,922 | 156,936 | 131,477 | 106,382 | 78,569 |
| Operating Income | 342,759 | 130,012 | 108,584 | 92,783 | 70,466 |
| Interest Expense | 8,172 | 2,040 | 2,084 | 2,846 | 2,894 |
| Other Income | -248,814 | 992 | 2,995 | 1,635 | 221 |
| Pre-tax Income | 85,773 | 128,964 | 109,495 | 91,572 | 67,793 |
| Income Tax | 77,365 | 49,229 | 39,810 | 34,927 | 26,337 |
| Net Income Continuous | 203,708 | 79,735 | 69,685 | 56,645 | 41,706 |
| Net Income Discontinuous | 0 | 0 | 0 | 0 | 250 |
| Net Income | $8,408 | $79,735 | $69,685 | $56,645 | $41,706 |
| EPS Basic Total Ops | 0.01 | 0.20 | 0.18 | 0.14 | 0.11 |
| EPS Basic Continuous Ops | 0.29 | 0.20 | 0.18 | 0.14 | 0.11 |
| EPS Diluted Total Ops | 0.01 | 0.20 | 0.18 | 0.14 | 0.11 |
| EPS Diluted Continuous Ops | 0.29 | 0.20 | 0.18 | 0.14 | 0.11 |
| EBITDA(a) | $382,271 | $139,114 | $114,949 | $97,372 | $73,889 |